Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konen Obayashi

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
The Biochemical Journal|June 15, 2011
Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosisHirofumi Jono, Takayuki Anno, Keiichi Motoyama, et al.
Surgery Today|August 30, 2011
Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantationYuki Ohya, Sadahisa Okamoto, Masayoshi Tasaki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2011
Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem studyMitsuharu Ueda, Yoko Horibata, Makoto Shono, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 25, 2012
Potential use of glucuronylglucosyl-β-cyclodextrin as a novel therapeutic tool for familial amyloidotic polyneuropathyHirofumi Jono, Takayuki Anno, Keiichi Motoyama, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S)Taku Nakase, Taro Yamashita, Yoshimasa Matsuo, et al.
Neurology|September 29, 2019
Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosisTaro Yamashita, Mitsuharu Ueda, Toshiya Nomura, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 4, 2011
Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathyTomoe Kugimiya, Hirofumi Jono, Shiori Saito, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 11, 2012
[Recognition of the importance of reversed CPC in CPC]Shinichiro Kanai, Go Matsumoto, Kenji Sano, et al.
BMJ Case Reports|August 22, 2012
Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patientKonen Obayashi, Mitsuharu Ueda, Toshinori Oshima, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 2004
LCAT-dependent conversion rate is a determinant of plasma prebeta1-HDL concentration in healthy JapaneseTakashi Miida, Konen Obayashi, Utako Seino, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
The Biochemical Journal|June 15, 2011
Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosisHirofumi Jono, Takayuki Anno, Keiichi Motoyama, et al.
Surgery Today|August 30, 2011
Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantationYuki Ohya, Sadahisa Okamoto, Masayoshi Tasaki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2011
Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem studyMitsuharu Ueda, Yoko Horibata, Makoto Shono, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 25, 2012
Potential use of glucuronylglucosyl-β-cyclodextrin as a novel therapeutic tool for familial amyloidotic polyneuropathyHirofumi Jono, Takayuki Anno, Keiichi Motoyama, et al.
Internal Medicine (Tokyo, Japan)|June 11, 2019
Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S)Taku Nakase, Taro Yamashita, Yoshimasa Matsuo, et al.
Neurology|September 29, 2019
Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosisTaro Yamashita, Mitsuharu Ueda, Toshiya Nomura, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 4, 2011
Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathyTomoe Kugimiya, Hirofumi Jono, Shiori Saito, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 11, 2012
[Recognition of the importance of reversed CPC in CPC]Shinichiro Kanai, Go Matsumoto, Kenji Sano, et al.
BMJ Case Reports|August 22, 2012
Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patientKonen Obayashi, Mitsuharu Ueda, Toshinori Oshima, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 2004
LCAT-dependent conversion rate is a determinant of plasma prebeta1-HDL concentration in healthy JapaneseTakashi Miida, Konen Obayashi, Utako Seino, et al.
Pageof 13